Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
Acorda Therapeutics, Inc.   (ticker: ACOR)
Quote:() Quotes on: Yahoo | Google
5 day's Perf: 100%
1 Month Perf: 100%
3 Month Perf: 100%
YTD Perf: 100%
1 Year Perf: 100%
Stock chart
Useful Quick Links for ACOR
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :          Hold          (Click Here For Details)
INSIDERS' Score: 45
0 100 45
Latest 1 month: 0 0
Latest 6 Months: 0 0
52 Weeks: 0 1,747,105
Gurus' Indicator :          Sell          (Click Here For Details)
GURUS' Score: 30
0 100 30
Current Holdings: 4,311,982
Previous Holdings: 5,328,967
Change: 19.08%
Institutions' Indicator :          Hold          (Click Here For Details)
0 100 45
Current Holdings: 46,449,997
Previous Holdings: 48,776,535
Change: 4.77%
News And Links For The Group (Contribute a link)
[ACOR]   Acorda: Time To Catch The Falling Knife?  (Seeking Alpha)   6-Aug-19 17:42
[ACOR]   Acorda Oversold: Runway To Positive Cash Flow  (Seeking Alpha)   3-Jul-19 11:52
[ACOR]   BIIB Is For Buy-O-Gen  (Seeking Alpha)   12-Jun-19 10:30
[ACOR]   Adamas Pharmaceuticals: Was It Overrated?  (Seeking Alpha)   27-May-19 16:11
[ACOR]   New Hope For Acorda Therapeutics In 2019  (Seeking Alpha)   28-Jan-19 16:07
[ACOR]   Acorda Gets Much Needed FDA Approval To Counter Patent Setback  (Seeking Alpha)   31-Dec-18 13:17
[ACOR]   Acorda's INBRIJA Receives Thumbs Up From FDA And Thumbs Down From Analysts  (Seeking Alpha)   28-Dec-18 18:37
[ACOR]   Adamas Knife Continues To Fall As Value Continues To Rise  (Seeking Alpha)   26-Dec-18 14:59
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*